| Factor Information | |
|---|---|
| Data ID | 2967 |
| Factor | mortality event rates of hyponatraemic(after 1 year follow up) |
| Description | The difference in event rates between hypona traemic and non-hyponatraemic patients was already evident after 1 year of follow up. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | prognostic implications of hyponatraemia in ACHD |
| p Value | <0.0001 |
| Conclusion | The difference in mortality event rates between hypona traemic and non-hyponatraemic patients was already evident after 1 year of follow up. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 642 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
| Reference | |
|---|---|
| PMID | 19933692 |
| Year | 2010 |
| Title | Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | patients' data | |
| Region | London, UK | |
| Method | Fisher's test | |
| Race | British | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ACHD with sodium <136mmol/L(Treatment) | ACHD with sodium >136mmol/L(Control) |
| Number | 16 | 17 |
| Age | 37.4±15.8 | 35.9±14.1 |
| Gender (Male: Female) | 73:83 | 416:432 |
| Marker Level | 10%(hypona traemic patients) | 2%(without hypona traemic patients) |
